Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts
Earnings Call Transcript

Veerhealth Care Earnings Call Transcript: Key Takeaways

Veerhealth is aggressively scaling through contract manufacturing for top FMCG players. The 3x revenue target for FY27 hinges on successful capacity expansion and international hotel supply orders.

Veerhealth Care Ltd NSE: NIYATILEAS Alert sent Call transcript
Why this was an Alfa AlertManagement guides 200% Revenue growth for FY27 (explicit single-year guidance).
Guidance and delivery
Management target Revenue 200.0% FY27
Highlights
Revenue growthExceptional growth; Q1 revenue matched the entire previous financial year.
MarginsExpects expansion through automation and economies of scale.
Order bookRobust; secured significant repeat skin care and face care orders.
Demand visibilityStrong visibility through long-term FMCG and US government supply contracts.
Management confidenceHighly optimistic, driven by new large-scale FMCG contracts.

Growth

Revenue hit ₹25 Cr in Q1 FY27, matching the entire previous year's turnover.

Outlook

Targets ₹100 Cr revenue and ₹5-6 Cr PAT for FY27.

Risks

High customer concentration in contract manufacturing and execution risk of the Vapi expansion.

Source

Earnings Call Transcript filed with BSE, NSE: NIYATILEAS. Summary written with AI assistance from the document.

Read the document ↗

Veerhealth Care Ltd: key numbers

Share price
₹48.88
Market cap
₹97.75 Cr
Revenue (annual)
₹32.48 Cr
Net profit (annual)
₹0.54 Cr
P/E (TTM)
63.9×Sector 46.1×
Promoter holding
31.88%-0.03% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Veerhealth Care Ltd

All →